Correction to: Efficacy of Dabrafenib for three children with brainstem BRAF positive ganglioglioma.

In the original article, the author names were published incorrectly. The names are correct in this publication.

Efficacy of Dabrafenib for three children with brainstem BRAF positive ganglioglioma.

Purpose: Children with unresectable brainstem-infiltrated ganglioglioma have poor progression-free survival when treated with conventional chemotherapy and radiation regimens. The BRAF mutation occurs in a large number of gangliogliomas, making them amenable for targeted therapy using mutation-specific kinase inhibitors. However, limited data exists on the effectiveness and best treatment duration of these inhibitors in this tumor setting.

Trametinib for progressive pediatric low-grade gliomas.

Introduction: Pediatric pilocytic astrocytomas (PAs) are low grade gliomas and the most common brain tumors in children. They often represent a therapeutic challenge when incompletely resected as they can recur and progress despite the use of several lines of chemotherapeutic agents or even radiation therapy. Genetic alterations leading to activation of the mitogen-activated-protein-kinase pathway are a hallmark of this disease and offer an interesting therapeutic alternative through the use of targeted inhibitors.

Neurotrophin receptors expression and JNK pathway activation in human astrocytomas.

Background: Neurotrophins are growth factors that regulate cell growth, differentiation and apoptosis in the nervous system. Their diverse actions are mediated through two different transmembrane - receptor signaling systems: Trk receptor tyrosine kinases (TrkA, TrkB, TrkC) and p75NTR neurotrophin receptor. Trk receptors promote cell survival and differentiation while p75NTR induces, in most cases, the activity of JNK-p53-Bax apoptosis pathway or suppresses intracellular survival signaling cascades.

Expression of p75NTR and Trk neurotrophin receptors in the enteric nervous system of human adults.

Recent evidence suggests that the expression of p75NTR and Trk neurotrophin receptors is essential for neuronal survival, not only during development, but also in adulthood. The aim of the present study was to investigate the cell localization and distribution of p75NTR and Trk receptors in the normal adult human enteric nervous system (ENS) using double-label immunohistochemistry. Immunoreactivity for p75NTR was observed in a few neurons, whereas Trk immunoreactivity was present in a higher percentage of neurons.